EN
Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis
Öz
Objective: The aim of this study was to compare serum and synovial fluid levels of matrix metalloproteinase-13 (MMP-13) and tumor necrosis factor-alpha (TNF-α) in 2 stages of osteoarthritis, and investigate their correlation with Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores.
Methods: Forty-two patients (mean age: 64±8.8 years) with grade 3 and grade 4 knee osteoarthritis according to Kellgren-Lawrence criteria were enrolled in the study and underwent total knee arthroplasty. TNF-α and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via enzyme-linked immunosorbent assay. Preoperative and 1-month postoperative knee functions were assessed by WOMAC.
Results: Grade 4 synovial fluid MMP-13 (4.76±5.82 pg/ml) was elevated compared to grade 3 (3.95±4.45), whereas grade 3 serum MMP-13 (1.128±0.308 pg/ml) was found elevated compared to grade 4 (1.038±0.204) (p=0.438, p=0.430, respectively). Grade 4 serum TNF-α (0.253±0.277) was elevated compared to grade 3 (0.206±0.219), whereas grade 3 synovial fluid TNF-α (0.129±0.052) was elevated compared to grade 4 (0.118±0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α (0.226±0.246 pg/ml) was elevated compared to synovial levels (0.124±1.59), and synovial MMP-13 (4.31±1.24) was elevated compared to serum levels (1.089±1.519).
Conclusion: Despite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner, with a significant correlation with WOMAC scores.
Methods: Forty-two patients (mean age: 64±8.8 years) with grade 3 and grade 4 knee osteoarthritis according to Kellgren-Lawrence criteria were enrolled in the study and underwent total knee arthroplasty. TNF-α and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via enzyme-linked immunosorbent assay. Preoperative and 1-month postoperative knee functions were assessed by WOMAC.
Results: Grade 4 synovial fluid MMP-13 (4.76±5.82 pg/ml) was elevated compared to grade 3 (3.95±4.45), whereas grade 3 serum MMP-13 (1.128±0.308 pg/ml) was found elevated compared to grade 4 (1.038±0.204) (p=0.438, p=0.430, respectively). Grade 4 serum TNF-α (0.253±0.277) was elevated compared to grade 3 (0.206±0.219), whereas grade 3 synovial fluid TNF-α (0.129±0.052) was elevated compared to grade 4 (0.118±0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α (0.226±0.246 pg/ml) was elevated compared to synovial levels (0.124±1.59), and synovial MMP-13 (4.31±1.24) was elevated compared to serum levels (1.089±1.519).
Conclusion: Despite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner, with a significant correlation with WOMAC scores.
Anahtar Kelimeler
Ayrıntılar
Birincil Dil
İngilizce
Konular
-
Bölüm
-
Yayımlanma Tarihi
26 Nisan 2016
Gönderilme Tarihi
17 Kasım 2015
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2016 Cilt: 50 Sayı: 3
APA
Özler, K., Aktaş, E., Atay, Ç., Yılmaz, B., Arıkan, M., & Güngör, Ş. (2016). Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis. Acta Orthopaedica et Traumatologica Turcica, 50(3), 356. https://izlik.org/JA72JY67RS
AMA
1.Özler K, Aktaş E, Atay Ç, Yılmaz B, Arıkan M, Güngör Ş. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis. Acta Orthopaedica et Traumatologica Turcica. 2016;50(3):356. https://izlik.org/JA72JY67RS
Chicago
Özler, Kenan, Erdem Aktaş, Çiğdem Atay, Barış Yılmaz, Murat Arıkan, ve Şafak Güngör. 2016. “Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis”. Acta Orthopaedica et Traumatologica Turcica 50 (3): 356. https://izlik.org/JA72JY67RS.
EndNote
Özler K, Aktaş E, Atay Ç, Yılmaz B, Arıkan M, Güngör Ş (01 Nisan 2016) Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis. Acta Orthopaedica et Traumatologica Turcica 50 3 356.
IEEE
[1]K. Özler, E. Aktaş, Ç. Atay, B. Yılmaz, M. Arıkan, ve Ş. Güngör, “Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis”, Acta Orthopaedica et Traumatologica Turcica, c. 50, sy 3, s. 356, Nis. 2016, [çevrimiçi]. Erişim adresi: https://izlik.org/JA72JY67RS
ISNAD
Özler, Kenan - Aktaş, Erdem - Atay, Çiğdem - Yılmaz, Barış - Arıkan, Murat - Güngör, Şafak. “Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis”. Acta Orthopaedica et Traumatologica Turcica 50/3 (01 Nisan 2016): 356. https://izlik.org/JA72JY67RS.
JAMA
1.Özler K, Aktaş E, Atay Ç, Yılmaz B, Arıkan M, Güngör Ş. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis. Acta Orthopaedica et Traumatologica Turcica. 2016;50:356.
MLA
Özler, Kenan, vd. “Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis”. Acta Orthopaedica et Traumatologica Turcica, c. 50, sy 3, Nisan 2016, s. 356, https://izlik.org/JA72JY67RS.
Vancouver
1.Kenan Özler, Erdem Aktaş, Çiğdem Atay, Barış Yılmaz, Murat Arıkan, Şafak Güngör. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis. Acta Orthopaedica et Traumatologica Turcica [Internet]. 01 Nisan 2016;50(3):356. Erişim adresi: https://izlik.org/JA72JY67RS